abemaciclib mesylate

Overview

Abemaciclib mesylate is a CDK inhibitor with selectivity for CDK4 and CDK6. It was approved for the treatment of advanced or metastatic breast cancers.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | CDK

Product Information

• Catalog No.: B2693-463381
• CAS No.: 1231930-82-7
• Molecular Formula: C28H36F2N8O3S
• Molecular Weight: 602.706

Source

Original product source